James M. Daly - Jun 15, 2021 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Stock symbol
BLCM
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
7/7/2021, 08:23 PM
Next filing
Jun 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $0 +6.5K $0.00 6.5K Jun 15, 2021 Common Stock 6.5K $3.05 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.